Takahiro Hirayama
Papers
1
Total Citations
37
H-Index
1
About
Takahiro Hirayama is a leading urologic surgeon whose work focuses on advancing minimally invasive surgical techniques for bladder cancer treatment. His most impactful research centers on comparing robot-assisted laparoscopic radical cystectomy (RALC) with traditional laparoscopic and open surgical approaches. In his landmark 2017 study, which has garnered 37 citations, Hirayama demonstrated that RALC is a safe and effective alternative to both laparoscopic and open radical cystectomy, providing crucial perioperative outcome data from a single-center experience spanning nearly a decade. This work has helped establish robotic surgery as a viable option for patients with bladder cancer, offering potential benefits in recovery and surgical precision. By systematically analyzing 36 consecutive patients treated between 2008 and 2017, Hirayama provided valuable evidence that has influenced clinical decision-making in urologic oncology. His contributions are particularly significant for surgeons seeking to adopt or refine robotic techniques, and his findings continue to shape best practices in bladder cancer management.
Research Focus
Key Achievements
Top Papers
- 1